Lawrence Feldman

7.0k total citations
83 papers, 945 citations indexed

About

Lawrence Feldman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lawrence Feldman has authored 83 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Lawrence Feldman's work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Lawrence Feldman is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Lawrence Feldman collaborates with scholars based in United States, Canada and Singapore. Lawrence Feldman's co-authors include Mary Pasquinelli, Matthew Koshy, Kevin L. Kovitz, Ronald B. Natale, Robert F. Todd, Marianne L. Durham, Patricia W. Finn, Klara Valyi‐Nagy, Li Liu and Kristen B. Pytynia and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lawrence Feldman

76 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Feldman United States 17 391 386 225 126 104 83 945
Viljem Kovač Slovenia 20 641 1.6× 292 0.8× 247 1.1× 45 0.4× 136 1.3× 69 1.0k
Cristian Villanueva France 16 508 1.3× 706 1.8× 229 1.0× 226 1.8× 301 2.9× 54 1.2k
Thomas J. Semrad United States 15 237 0.6× 395 1.0× 257 1.1× 46 0.4× 162 1.6× 51 890
Youling Gong China 21 662 1.7× 534 1.4× 439 2.0× 89 0.7× 178 1.7× 89 1.4k
Luciano de Souza Viana Brazil 18 396 1.0× 492 1.3× 342 1.5× 225 1.8× 223 2.1× 37 968
Alex Guminski Australia 16 445 1.1× 709 1.8× 272 1.2× 208 1.7× 201 1.9× 35 1.1k
Petr Szturz Czechia 18 350 0.9× 494 1.3× 269 1.2× 427 3.4× 141 1.4× 85 1.2k
J.-P. Machiels Belgium 13 412 1.1× 544 1.4× 291 1.3× 412 3.3× 129 1.2× 34 1.1k
Jiřı́ Petera Czechia 18 369 0.9× 344 0.9× 128 0.6× 65 0.5× 137 1.3× 108 969
Edgardo S. Santos United States 21 524 1.3× 576 1.5× 384 1.7× 25 0.2× 230 2.2× 101 1.2k

Countries citing papers authored by Lawrence Feldman

Since Specialization
Citations

This map shows the geographic impact of Lawrence Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Feldman more than expected).

Fields of papers citing papers by Lawrence Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Feldman. The network helps show where Lawrence Feldman may publish in the future.

Co-authorship network of co-authors of Lawrence Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Feldman. A scholar is included among the top collaborators of Lawrence Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Feldman. Lawrence Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Furqan, Muhammad, Lawrence Feldman, Greg Andrew Durm, et al.. (2025). 2761O Chemo-immunotherapy followed by durvalumab and ceralasertib in treatment naïve patients with extensive-stage small cell lung cancer. Annals of Oncology. 36. S1369–S1370.
3.
Pasquinelli, Mary, et al.. (2024). Characterization of DNA damage repair mutations in lung cancer in an underserved urban patient population.. Journal of Clinical Oncology. 42(16_suppl). e20058–e20058. 1 indexed citations
4.
5.
6.
Hamlish, Tamara, Mary Pasquinelli, Michael T. Huber, et al.. (2022). A team-based approach to effective management of pain and opioid use disorder in patients with cancer: Case report. SHILAP Revista de lepidopterología. 8. 100196–100196.
7.
8.
9.
Kennedy, Kathleen, Alicia Hulbert, Mary Pasquinelli, & Lawrence Feldman. (2022). Impact of CT screening in lung cancer: Scientific evidence and literature review. Seminars in Oncology. 49(3-4). 198–205. 9 indexed citations
10.
Aissa, Alexandre F., Abul Bashar Mir Md. Khademul Islam, Majd Ariss, et al.. (2021). Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer. Nature Communications. 12(1). 1628–1628. 143 indexed citations
11.
Pasquinelli, Mary, Martin C. Tammemägi, Kevin L. Kovitz, et al.. (2020). Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. Journal of Thoracic Oncology. 15(11). 1738–1747. 71 indexed citations
12.
Pasquinelli, Mary, Kevin L. Kovitz, Marianne L. Durham, et al.. (2019). P1.11-06 Expanding Criteria for Lung Cancer Screening Reduces Gender Disparity. Journal of Thoracic Oncology. 14(10). S517–S517. 1 indexed citations
13.
Huang, Lei, Odile David, Robert J. Cabay, et al.. (2018). Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer. Clinical Cancer Research. 25(6). 1795–1808. 22 indexed citations
14.
Shergill, Ardaman, Muhammad Furqan, Jyoti Malhotra, et al.. (2018). P1.01-86 BTCRC-LUN15-017: Phase-Ib Study of Imprime PGG and Pembrolizumab in Stage IV NSCLC after Progression on Platinum Based Therapy. Journal of Thoracic Oncology. 13(10). S496–S496. 1 indexed citations
15.
Agulnik, Mark, et al.. (2005). Paclitaxel, Carboplatin, and Concomitant Radiotherapy for Resected Patients with High Risk Head and Neck Cancer. Journal of Chemotherapy. 17(2). 237–241.
16.
Feldman, Lawrence. (2004). Risk Management At A Brownfields Site:A Case Study In Long-term Stewardship. WIT Transactions on Ecology and the Environment. 70. 1 indexed citations
17.
Feldman, Lori, Sandra Allen, Gail Shiomoto, et al.. (2004). Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell disease. American Journal of Hematology. 77(4). 407–409. 5 indexed citations
18.
Feldman, Lawrence, et al.. (2003). Sustaining Risk-informed Decision Making (RIDM) Measures. WIT Transactions on Ecology and the Environment. 63.
19.
Feldman, Lawrence, et al.. (2002). Successful Redevelopment And Risk Management In Emeryville, California. WIT Transactions on Ecology and the Environment. 55. 1 indexed citations
20.
Wickrema, Amittha, Fei Chen, Sarfraz Ahmad, et al.. (1999). Defective expression of the SHP-1 phosphatase in polycythemia vera. Experimental Hematology. 27(7). 1124–1132. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viljem Kovač Breakdown of academic impact, for papers by Cristian Villanueva Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Youling Gong Breakdown of academic impact, for papers by Luciano de Souza Viana Breakdown of academic impact, for papers by Alex Guminski Breakdown of academic impact, for papers by Petr Szturz Breakdown of academic impact, for papers by J.-P. Machiels Breakdown of academic impact, for papers by Jiřı́ Petera Breakdown of academic impact, for papers by Edgardo S. Santos
Rankless by CCL
2026